
James Michael Orcutt MD
community leader and principal investigator for the Southeastern Cancer Control Consortium and Roper St. Francis Cancer Center Bon Secours St Francis Hospital, Colleton Medical Center and East Cooper Medical Center.
Join to View Full Profile
2085 Henry Tecklenburg DrFl 2Charleston, SC 29414
Phone+1 843-577-6957
Dr. Orcutt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 1993 - 1996
- Carolinas Medical CenterResidency, Internal Medicine, 1990 - 1993
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1990
Certifications & Licensure
- NC State Medical License 1991 - 2025
- SC State Medical License 1996 - 2025
- VA State Medical License 1993 - 2018
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jul 19
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsCorrection to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzuma...Samuel A Jacobs, André Robidoux, Jame Abraham, José Manuel Pérez-Garcia, Nicla La Verde
Breast Cancer Research. 2020-01-22 - 24 citationsNSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2breast...Samuel A Jacobs, André Robidoux, Jame Abraham, José Manuel Pérez-Garcia, Nicla La Verde
Breast Cancer Research. 2019-12-03 - 412 citationsFirst-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Bioma...Neal Ready, Matthew D. Hellmann, Mark M. Awad, Gregory A. Otterson, Martin Gutierrez
Journal of Clinical Oncology. 2019-02-20
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: